Next Article in Journal
Anti- and Pro-Lipase Activity of Selected Medicinal, Herbal and Aquatic Plants, and Structure Elucidation of an Anti-Lipase Compound
Next Article in Special Issue
Isolation, Structural Analyses and Biological Activity Assays against Chronic Lymphocytic Leukemia of Two Novel Cytochalasins — Sclerotionigrin A and B
Previous Article in Journal
Liposomal Encapsulation Enhances In Vivo Near Infrared Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model
Previous Article in Special Issue
Differential Growth Inhibitory Effects of Highly Oxygenated Guaianolides Isolated from the Middle Eastern Indigenous Plant Achillea falcata in HCT-116 Colorectal Cancer Cells
Molecules 2013, 18(12), 14629-14650; doi:10.3390/molecules181214629
Article

Bio-Activity and Dereplication-Based Discovery of Ophiobolins and Other Fungal Secondary Metabolites Targeting Leukemia Cells

1,†
, 2,†
, 1
, 1
, 1
, 3
, 2,*  and 1,*
Received: 12 October 2013; in revised form: 15 November 2013 / Accepted: 21 November 2013 / Published: 26 November 2013
(This article belongs to the Special Issue Bioassay-Guided Isolation of Natural Products)
Download PDF [746 KB, uploaded 18 June 2014]
Abstract: The purpose of this study was to identify and characterize fungal natural products (NPs) with in vitro bioactivity towards leukemia cells. We based our screening on a combined analytical and bio-guided approach of LC-DAD-HRMS dereplication, explorative solid-phase extraction (E-SPE), and a co-culture platform of CLL and stromal cells. A total of 289 fungal extracts were screened and we tracked the activity to single compounds in seven of the most active extracts. The novel ophiobolin U was isolated together with the known ophiobolins C, H, K as well as 6-epiophiobolins G, K and N from three fungal strains in the Aspergillus section Usti. Ophiobolins A, B, C and K displayed bioactivity towards leukemia cells with induction of apoptosis at nanomolar concentrations. The remaining ophiobolins were mainly inactive or only slightly active at micromolar concentrations. Dereplication of those ophiobolin derivatives possessing different activity in combination with structural analysis allowed a correlation of the chemical structure and conformation with the extent of bioactivity, identifying the hydroxy group at C3 and an aldehyde at C21, as well as the A/B-cis ring structure, as indispensible for the strong activity of the ophiobolins. The known compounds penicillic acid, viridicatumtoxin, calbistrin A, brefeldin A, emestrin A, and neosolaniol monoacetate were identified from the extracts and also found generally cytotoxic.
Keywords: natural products; ophiobolin U; dereplication; explorative solid phase extraction (E-SPE); filamentous fungi; cytotoxic; cancer; leukemia natural products; ophiobolin U; dereplication; explorative solid phase extraction (E-SPE); filamentous fungi; cytotoxic; cancer; leukemia
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Bladt, T.T.; Dürr, C.; Knudsen, P.B.; Kildgaard, S.; Frisvad, J.C.; Gotfredsen, C.H.; Seiffert, M.; Larsen, T.O. Bio-Activity and Dereplication-Based Discovery of Ophiobolins and Other Fungal Secondary Metabolites Targeting Leukemia Cells. Molecules 2013, 18, 14629-14650.

AMA Style

Bladt TT, Dürr C, Knudsen PB, Kildgaard S, Frisvad JC, Gotfredsen CH, Seiffert M, Larsen TO. Bio-Activity and Dereplication-Based Discovery of Ophiobolins and Other Fungal Secondary Metabolites Targeting Leukemia Cells. Molecules. 2013; 18(12):14629-14650.

Chicago/Turabian Style

Bladt, Tanja T.; Dürr, Claudia; Knudsen, Peter B.; Kildgaard, Sara; Frisvad, Jens C.; Gotfredsen, Charlotte H.; Seiffert, Martina; Larsen, Thomas O. 2013. "Bio-Activity and Dereplication-Based Discovery of Ophiobolins and Other Fungal Secondary Metabolites Targeting Leukemia Cells." Molecules 18, no. 12: 14629-14650.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert